Government support for the vaccine “increases our confidence in its success,” an analyst said.
How quickly a vaccine could win regulatory approval has been the subject of much debate on Wall Street.
The enthusiasm for airline stocks is spurring massive inflows in the exchange-traded fund market.
More than 300,000 eligible patients in the U.S. won’t have access to the California-based company’s treatment.
The U.S. Food and Drug Administration is expediting development and review of new products to fight Covid-19.
Some companies are expected to buck the trend of companies dropping their dividend.
His specific policies are being more closely analyzed now that he's perceived to be the primary winner.
Wall Street looks on a candidacy of the former vice president more favorably than that of Senator Bernie Sanders.
Karuna Therapeutics has had a remarkable run since its June IPO.
The investment firm founded by Felix and Julian Baker made a big bet in the company.